Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children
Phase 3
Active, not recruiting
- Conditions
- Autism Spectrum Disorder
- Interventions
- Drug: Placebo of AST-001
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Astrogen, Inc.
- Target Recruit Count
- 169
- Registration Number
- NCT06333964
- Locations
- 🇰🇷
Soon Chun Hyang University Hospital Cheonan, Cheonan, Chungcheongnam-do, Korea, Republic of
🇰🇷Hallym University Medical Center, Anyang, Gyeonggi-do, Korea, Republic of
🇰🇷Samsung Changwon Medical Center, Changwon, Gyeongsangnam-do, Korea, Republic of
News
No news found